Stanford BMT-CT ASH Abstracts 2025
Travel time and insurance status as determinants of specialized leukemia care access in adolescents and young adult (AYA) patients with acute lymphoblastic leukemia (ALL)
Lori Muffly, Helen Parsons, Katharine Miller, Jerry Luo, Amy Zhang, Theresa Keegan
Abstract Number: abs25-1557
Presentation ID 283 - Saturday, December 6, 02:00 PM - 02:15 PM EST at OCCC - W224ABEF
https://meetings-api.hematology.org/api/abstract/vmpreview/290202
A Phase 1 study of KITE-753 or KITE-363 in patients with relapsed/refractory B-cell lymphoma: Initial safety and preliminary efficacy of KITE-753 and updated results of KITE-363
Saurabh Dahiya, Matthew Ulrickson, Jean Yared, Patrick Reagan, Timothy Voorhees, Ran Reshef, Cameron Turtle, Lizamarie Bachier-Rodriguez, Marie José Kersten, Max S Topp, Gary Simmons, Robin Sanderson, Loretta Nastoupil, Scott Jung, Enrique Granados, Jinghui Dong, Joshua Winters, Rhine Shen, Justyna Kanska, Myrna Nahas, Sairah Ahmed
Abstract Number: abs25-2341
Presentation ID 265 - Saturday, December 6, 02:00 PM - 02:15 PM EST at OCCC - West Hall D2
https://meetings-api.hematology.org/api/abstract/vmpreview/290986
Enhancing the safety of ciltacabtagene autoleucel in relapsed multiple myeloma (MM): Identification of potentially modifiable risk-factors associated with delayed neurotoxicity and non-relapse mortality
Surbhi Sidana, Brett Reid, Danai Dima, Lauren Peres, Mahmoud Gaballa, Rahul Banerjee, Oren Pasvolsky, Aimaz Afrough, Christen Dillard, Christopher Ferreri, Shebli Atrash, Cindy Varga, Andrew Portuguese, Masooma Rana, Hitomi Hosoya, Lekha Mikkilineni, Vanna Hovanky, Saurabh Zanwar, Nilesh Kalariya, Damian Mikulski, Charlotte Wagner, Christopher Cahoon, Omar Alexis Castaneda Puglianini, Gabriel De Avila, Christian Gordillo, Eli Zolotov, Ariel Grajales-Cruz, Utkarsh Goel, Aishwarya Sannareddy, Jeries Kort, Raffaella Cassano, Shonali Midha, James Davis, Rebecca Gonzalez, Megan Herr, Zhuoer Xie, Hamza Hassan, Sneha Purvey, Marcus Geer, Kimberly Green, Fabiana Perna, Hien Liu, Taiga Nishihori, Jack Khouri, Shahzad Raza, Faiz Anwer, Susan Bal, Omar Nadeem, Ciara Louise Freeman, Leyla Shune, Ran Reshef, Kenneth Shain, Melissa Alsina, Rachid Baz, Douglas Sborov, Saurabh Dahiya, Frederick Locke, David Miklos, Peter Voorhees, Larry Anderson, Luciano Costa, Noa Biran, Yi Lin, Krina Patel, Doris Hansen
Abstract Number: abs25-2357
Presentation ID 1034 - Monday, December 8, 04:45 PM - 05:00 PM EST at OCCC - West Hall D1
https://meetings-api.hematology.org/api/abstract/vmpreview/291002
Evaluating thymic stromal lymphopoietin (TSLP) as a biomarker in acute graft versus host disease
Parveen Shiraz, Ioannis Louloudis, Joanna Liliental, Shailja Patel, Alexandria Jensen, Sonia Fonseca, Kathy Le, Binta Diallo, Anna Pavlova, Sally Arai, Robert Negrin, Andrew Rezvani, Laura Johnston, Wen-Kai Weng, Robert Lowsky, Lori Muffly, David Miklos, Vanessa Kennedy, Everett Meyer, John Levine, James Ferrara, Judith Shizuru
Abstract Number: abs25-2622
Presentation ID 586 - Sunday, December 7, 12:45 PM - 01:00 PM EST at OCCC - Chapin Theater (W320)
https://meetings-api.hematology.org/api/abstract/vmpreview/291267
A single-arm, open-label, multi-center, phase 1b/2 Study to evaluate the safety, efficacy, and cellular pharmacokinetic profile of CTD402 in participants with relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LBL) (TENACITY-01)
Lori Muffly, Edward Abadir, Mark Geyer, Ryan Cassaday, Gregory Roloff, R. Alejandro Sica, Wendy Stock, Eileen McNulty, Maria Del Rosario, Xiao Shi, Yanbo Liu, Yong Yu, Yali Zhou, Ming Gao, Wengang Ge, Lu Han, Yajin Ni, Jiangtao Ren, Jan Davidson-Moncada, Nitin Jain
Abstract Number: abs25-3896
Presentation ID 5954 - Monday, December 8, 06:00 PM - 08:00 PM EST at OCCC - West Halls B3-B4
https://meetings-api.hematology.org/api/abstract/vmpreview/292541
Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial)
Matthew Frank, David Qualls, Armin Ghobadi, Jordan Gauthier, Michael Tees, Luke Mountjoy, Joseph McGuirk, Sattva Neelapu, Reem Karmali, Iris Isufi, Brian Hill, Craig Sauter, Catherine Diefenbach, Jay Spiegel, Lizamarie Bachier-Rodriguez, Monalisa Ghosh, Nirav Shah, Rahul Lakhotia, Francisco Hernandez-Ilizaliturri, Anuja Abhyankar, Elise Chong, Matthew Schwede, Krish Patel, Olalekan Oluwole, John Baird, Nathan Denlinger, Farrukh Awan, Michael Jain, John Timmerman, Cesar Sanchez, Muthu Kumaran, Jean Yared, Jon Arnason, Ishan Tatake, Usama Gergis, Peter Riedell, Keith Pratz, Nirali Shah
Abstract Number: abs25-7393
Presentation ID 667 - Sunday, December 7, 04:30 PM - 04:45 PM EST at OCCC - Tangerine Ballroom F3-4
https://meetings-api.hematology.org/api/abstract/vmpreview/296038
Quality-adjusted survival analysis of neurologic events with ciltacabtagene autoleucel (Cilta-cel) vs standard of care (SOC) in patients (Pts) with lenalidomide-refractory multiple myeloma (MM) who received 1–3 prior lines of therapy (LOT): Cartitude-4 trial population (Pop)
Surbhi Sidana, Leyla Shune, Luciano Costa, Roberto Mina, Rafal Slowik, Jianming He, João Mendes, Jackie Kwong, Maren Gaudig, Seina Lee, Mukta Sharma, Rakesh Popat, Cyrille Touzeau
Abstract Number: abs25-8927
Presentation ID 5768 - Monday, December 8, 06:00 PM - 08:00 PM EST at OCCC - West Halls B3-B4
https://meetings-api.hematology.org/api/abstract/vmpreview/297572
Optimal ferritin threshold to diagnose immune effector cell-associated hemophagocytic syndrome (IEC-HS) following CAR-T therapy in relapsed/refractory multiple myeloma (RRMM)
Jerry Lee, Alexandria Jensen, Hitomi Hosoya, Saurabh Zanwar, Oren Pasvolsky, Mahmoud Gaballa, Christen Dillard, Jack Khouri, Shahzad Raza, Utkarsh Goel, Faiz Anwer, Vanna Hovanky, Masooma Rana, James Davis, Kimberly Green, Aimaz Afrough, Larry Anderson, Noa Biran, Eli Zolotov, Megan Herr, Hamza Hassan, Leyla Shune, Jeries Kort, Christopher Ferreri, Shebli Atrash, Cindy Varga, Peter Voorhees, Douglas Sborov, Gliceida Fortuna, Kelley Julian, Danai Dima, Rahul Banerjee, Ciara Louise Freeman, Andrew Portuguese, Raffaella Cassano, Frederick Locke, Karla J Salva, Lauren Peres, Brett Reid, Omar Alexis Castaneda Puglianini, Ariel Grajales-Cruz, Michael Jain, Krina Patel, Matthew Frank, Yi Lin, Doris Hansen, Surbhi Sidana, Nirali Shah, Lekha Mikkilineni
Abstract Number: abs25-10307
Presentation ID 717 - Sunday, December 7, 05:00 PM - 05:15 PM EST at OCCC - West Hall D1
https://meetings-api.hematology.org/api/abstract/vmpreview/298952
A subset of patients achieve prolonged remission beyond 3–5 years with FHVH33-CD8BBZ BCMA CAR T-cells for RRMM
Lekha Mikkilineni, Jennifer Mann, Genevieve Fromm, Alexandria Jensen, Micaela Ganadan, Danielle Natrakul, Jennifer Brudno, James Kochenderfer
Abstract Number: abs25-10612
Presentation ID 4162 - Sunday, December 7, 06:00 PM - 08:00 PM EST at OCCC - West Halls B3-B4
https://meetings-api.hematology.org/api/abstract/vmpreview/299257
Real-world outcomes in older adults with triple-class exposed multiple myeloma
Surbhi Sidana, Devender Dhanda, Sophie Hello, Jiaqi Fang, Gaurav Deshpande, Tao Gu, Luciano Costa
Abstract Number: abs25-11540
Presentation ID 6368 - Monday, December 8, 06:00 PM - 08:00 PM EST at OCCC - West Halls B3-B4
https://meetings-api.hematology.org/api/abstract/vmpreview/300185
Orca-T improves chronic graph-versus-host disease free in patients with a broad range of demographic and clinical variables: Results of randomized, Phase 3 trial
Everett Meyer, Amandeep Salhotra, Arpita Gandhi, Jeremy Pantin, Rasmus Hoeg, Alexandra Gomez Arteaga, Rawan Faramand, Roni Tamari, Edmund Waller, Satyajit Kosuri, Antonio Jimenez Jimenez, Jennifer Holter-Chakrabarty, Bhagirathbhai Dholaria, Yi-Bin Chen, Betty K. Hamilton, John Magenau, Alireza Eghtedar, Anna Pavlova, Nate Fernhoff, J. Scott McClellan, Scott Killian, Caspian Oliai, Robert Negrin, Sagar Patel
Abstract Number: abs25-14578
Presentation ID 2477 - Saturday, December 6, 05:30 PM - 07:30 PM EST at OCCC - West Halls B3-B4
https://meetings-api.hematology.org/api/abstract/vmpreview/303223
Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib
Mark Levis, Mehdi Hamadani, Brent Logan, Richard Jones, Anurag Singh, Mark Litzow, John Wingard, Esperanza Papadopoulos, Alexander Perl, Robert Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey Uy, Edmund Waller, Sumithira Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Heeje Kim, Matthias Stelljes, Yuho Najima, Masahiro Onozawa, Kirsty Thomson, Caroline Chen, Nahla Hasabou, Mathew Rosales, Jason Hill, Stanley Gill, Rishita Nuthethi, Denise King, Adam Mendizabal, Steven Devine, Mary Horowitz, Yi-Bin Chen
Abstract Number: abs25-1693
https://meetings-api.hematology.org/api/abstract/vmpreview/290338
Real-world outcomes with elranatamab in multiple myeloma: A multi-center analysis from the United States multiple myeloma immunotherapy consortium
Andrew Portuguese, James Davis, Shahzad Raza, Omar Alexis Castaneda Puglianini, Ciara Louise Freeman, Melissa Alsina, Corbin Wright, Utkarsh Goel, Jack Khouri, Faiz Anwer, Hossam M. Ali, Oren Pasvolsky, Mahmoud Gaballa, Krina Patel, Hector Garcia Pleitez, Damian Mikulski, Lindsay Fogel, Eli Zolotov, Aishwarya Sannareddy, Aimaz Afrough, Larry Anderson, Kelley Julian, Danai Dima, Rahul Banerjee, Emily Liang, Raffaella Cassano, Megan Herr, Hamza Hassan, Leyla Shune, Jeries Kort, Shonali Midha, Omar Nadeem, Surbhi Sidana, Yi Lin, Frederick Locke, Doris Hansen, Douglas Sborov, Noa Biran, Ariel Grajales-Cruz
Abstract Number: abs25-2557
https://meetings-api.hematology.org/api/abstract/vmpreview/291202
Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world
Aaron Logan, Fevzi Yalniz, Amy Zhang, Katharine Miller, Katherine Sutherland, Nikeshan Jeyakumar, Hrishikesh Srinagesh, Michael Grunwald, Vamsi Kota, Jacob Boccucci, Matthew Ulrickson, Ali AlDarobi, Joshua Sasine, LaQuisa Hill, Ibrahim Muhsen, Anjali Advani, Ibrahim Aldoss, Tamer Othman, Karamjeet Sandhu, Ran Reshef, Marlise Luskin, Evan Chen, Chenyu Lin, Ryan Cassaday, Noam Kopmar, Melhem Solh, Catherine Lee, Silvina Odstrcil Bobillo, Stephanie Tsai, Timothy O'Connor, Talal Hilal, Jae Park, Yannis Valtis, Sumithira Vasu, Evandro Bezerra, Eunice Wang, Jessica Leonard, Virginia Tan, Kristen O'Dwyer, Jozal Moore, Ross McCauley, Navneet Majhail, Luke Mountjoy, Aravind Ramakrishnan, Shahbaz Malik, Minoo Battiwalla, Paul Shaughnessy, John Mathews, Omer Jamy, Razan Mohty, Muthu Kumaran, Rasmus Hoeg, Wendy Stock, Gregory Roloff, Caspian Oliai, Georgia Lill, Marc Schwartz, Divya Koura, Kaitlyn Dykes, Michael Daunov, Ken Byrd, Veronika Bachanova, Sean Tracy, Punita Grover, Noelle Frey, Matthew Connor, George Yaghmour, Vivian Irizarry Gatell, Clayton Jackson, Olalekan Oluwole, Bhagirathbhai Dholaria, Rawan Faramand, Lori Muffly
Abstract Number: abs25-2558
https://meetings-api.hematology.org/api/abstract/vmpreview/291203
ZUMA-25 preliminary analysis: A Phase 2 study of brexucabtagene autoleucel (brexu-cel) in patients (Pts) with relapsed/refractory (R/R) burkitt lymphoma (BL), substudy C
Suzanne Van Dorp, Georg Stussi, Anna Maria Frustaci, Ian Flinn, Zachary Crees, John Baird, Luke Mountjoy, Saurabh Dahiya, Nadine Kutsch, Pier Luigi Zinzani, Armando Lopez-Guillermo, Philipp Staber, Loic Ysebaert, Ramon Garcia-Sanz, Fatima De la Cruz Vicente, Lori Leslie, David Bond, Bhagirathbhai Dholaria, Chad Williams, Lang Zhou, Ioana Kloos, Liana Nikolaenko, Enrico Tiacci
Abstract Number: abs25-2841
https://meetings-api.hematology.org/api/abstract/vmpreview/291486
Patient-reported outcomes (PROs) with lisocabtagene maraleucel (liso-cel) in patients with third line or later (3L+) R/R MZL from the Phase 2 TRANSCEND FL study
Reem Karmali, Franck Morschhauser, Koji Izutsu, Lia Palomba, Kirit Ardeshna, Brian Hill, Manali Kamdar, Stephen J. Schuster, Antonio Pinto, Saurabh Dahiya, Merav Bar, Maria Strocchia, Jinender Kumar, Jeremy Abramson
Abstract Number: abs25-2859
https://meetings-api.hematology.org/api/abstract/vmpreview/291504
Superior real-world outcomes of lisocabtagene maraleucel in chronic lymphocytic leukemia
Jennifer Huang, Jenna Voutsinas, Niranjan Khaire, Vincenzo Pizzuti, Leyla Shune, Matthew Lei, Rodrigo Fonseca, Mohammad Ammad Ud Din, Alan Skarbnik, Agrima Mian, Sushma Bharadwaj, Aseel Alsouqi, Bret Wankel, Graham Wehmeyer, Joseph Lukowski, Alexey Danilov, Tanya Siddiqi, Meghan Thompson, Michael Scordo, Stephanie Franco, Deborah Stephens, Chaitra Ujjani, Ryan Lynch, Jordan Gauthier, William Wierda, Paul Barr, Adam Kittai, Jonah Shulman, Matthew Lunning, Kerry Rogers, Bita Fakhri, Brian Hill, Javier Pinilla-Ibarz, Talal Hilal, Jacob Soumerai, Manali Kamdar, Qian Wu, Nitin Jain, Mazyar Shadman
Abstract Number: abs25-2882
https://meetings-api.hematology.org/api/abstract/vmpreview/291527
Efficacy and safety of frail adults treated with ciltacabtagene autoleucel in the real-world: A CIBMTR analysis
Hira Mian, Muhammad Salman Faisal, Tiening Chen, Ruta Brazauskas, Temitope Oloyede, Nausheen Ahmed, Aimaz Afrough, Larry Anderson, Rahul Banerjee, Jesús Berdeja, Aram Bidikian, Jakob Devos, Binod Dhakal, Ajoy Dias, Danai Dima, Yvonne Efebera, Lohith Gowda, Doris Hansen, Hamza Hashmi, Heather Landau, Lazaros Lekakis, Abu-Sayeef Mirza, Ravi Narra, Krina Patel, Ashley Rosko, Mark Schroeder, Surbhi Sidana, Saad Usmani, Marcelo Pasquini, Othman Akhtar, Taiga Nishihori, Meera Mohan
Abstract Number: abs25-4065
https://meetings-api.hematology.org/api/abstract/vmpreview/292710
The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission
Kai Yu, Laura Dillon, Jesse Tettero, Gege Gui, Rasha Al-Ali, Michael Grunwald, Elizabeth Krakow, Elizabeth Griffiths, Alexandra Gomez-Arteaga, Rahul Vedula, Melhem Solh, Amandeep Salhotra, Nelli Bejanyan, Lori Muffly, Antonio Jimenez-Jimenez, Michael Drazer, Yi-Bin Chen, Aaron Logan, Reena Jayani-Kosarzycki, Sophia Balderman, James Blachly, Brian Shaffer, Marc Schwartz, Cecilia Yeung, Lawrence Druhan, Vanessa Kennedy, Sandeep Gurbuxani, Melissa Tjota, Max Smith, Farah Sahoo, Dylan Barfield, Jim Guo, James Han, Jason Hu, Heejoon Jo, Vidya Kudlingar, Wilfred Li, Yutong Qiu, Pratheesh Sathyan, Sean Truong, Severine Catreux, Sam Ng, Khai Luong, Yunjiao Zhu, Reem Bahr, Jamie Diemer, Jianqun Kou, Stephanie Bo-Subait, Jackie Bjerke, Steven Devine, Bergetta Dietel, Christina Ferrone, Gabrielle Giammarino, Emily Heying, Emily Kolb, Danielle O'Donnell Vitali, Wael Saber, Stephen Spellman, Brenna Tesch, Jenny Vogel, Stephanie Waldvogel, Syreeta Weatherspoon, Jeffery Auletta, Christopher Hourigan
Abstract Number: abs25-4619
https://meetings-api.hematology.org/api/abstract/vmpreview/293264
Real world outcomes of bispecific T-cell engagers in plasma cell leukemia
Mahmoud Gaballa, Kelley Julian, Aimaz Afrough, Doris Hansen, Utkarsh Goel, Andre De Menezes Silva Corraes, Danai Dima, Masooma Rana, Hitomi Hosoya, Lekha Mikkilineni, Lindsay Fogel, Shahzad Raza, Rahul Banerjee, Saurabh Zanwar, Oren Pasvolsky, Aishwarya Sannareddy, Azra Borogovac, James Davis, Kimberly Green, Noa Biran, Megan Herr, Leyla Shune, Evguenia Bhurtel, Shebli Atrash, Christopher Ferreri, Tiffany Richards, Muhammad Bilal Abid, Susan Bal, Hossam M. Ali, J. Christine Ye, Shambavi Richard, Gurbakhash Kaur, Kenneth Shain, Omar Alexis Castaneda Puglianini, Adriana Rossi, Larry Anderson, Peter Voorhees, Jack Khouri, Surbhi Sidana, Andrew Portuguese, Murali Janakiram, Hans Lee, Yi Lin, Ariel Grajales-Cruz, Krina Patel, Douglas Sborov
Abstract Number: abs25-4651
https://meetings-api.hematology.org/api/abstract/vmpreview/293296
Outcomes of stem cell boost (SCB) versus supportive care alone for prolonged cytopenias after chimeric antigen receptor T cell therapy (CAR-T) in relapsed/refractory multiple myeloma (RRMM): A muli-center real-world analysis
Cindy Varga, Myra Robinson, James Davis, Hamza Hashmi, Thomas Martin, Anupama Kumar, Douglas Sborov, Charlotte Wagner, Doris Hansen, Omar Alexis Castaneda Puglianini, Leyla Shune, Evguenia Bhurtel, Aimaz Afrough, Larry Anderson, Binod Dhakal, Megan Herr, Shambavi Richard, Alex Lieberman-Cribbin, Daniel Sherbenou, Peter Forsberg, Sneha Purvey, Jack Khouri, Yi Lin, Surbhi Sidana, Shonali Midha, Asad Haider, Krina Patel, Mehmet Kocoglu, Christopher Ferreri
Abstract Number: abs25-4668
https://meetings-api.hematology.org/api/abstract/vmpreview/293313
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes at one year following transplantation: Results from the NMDP sponsored ACCESS study
Monzr M. Al Malki, Stephanie Bo-Subait, Brent Logan, Sarah Smith, Erin Leckrone, Heather Stefanski, Jeffery Auletta, Stephen Spellman, Craig Malmberg, Medhat Askar, Rachel Cusatis, Brian Shaffer, Dipenkumar Modi, Farhad Khimani, Mahasweta Gooptu, Mehdi Hamadani, Martin Maiers, Joseph Stanek, Javier Meade, Uttam Rao, Jordan Milner, Ramzi Abboud, Katarzyna Jamieson, George Carrum, Bhagirathbhai Dholaria, William Hogan, Ran Reshef, Satyajit Kosuri, Rachel Cook, Karen Ballen, Alison Loren, Karilyn Larkin, Sally Arai, Muna Qayed, Sung Choi, Larisa Broglie, Bronwen Shaw, Steven Devine, Antonio Jimenez Jimenez
Abstract Number: abs25-7189
https://meetings-api.hematology.org/api/abstract/vmpreview/295834
Safety and efficacy of talquetamab in patients with relapsed and refractory multiple myeloma (RRMM) with and without renal impairment (RI)
Laura Joiner, Oren Pasvolsky, Aimaz Afrough, Saurabh Zanwar, Rahul Banerjee, Raffaella Cassano Cassano, Mahmoud Gaballa, Kelley Julian, Ariel Grajales-Cruz, Melissa Alsina, Utkarsh Goel, Andre Corraes, Danai Dima, Masooma Rana, Hitomi Hosoya, Lekha Mikkilineni, Lindsay Fogel, Shahzad Raza, Hossam M. Ali, Aishwarya Sannareddy, Douglas Sborov, Azra Borogovac, Murali Janakiram, James Davis, Kimberly Green, Noa Biran, Hamza Hassan, Megan Herr, Leyla Shune, Evguenia Bhurtel, Shebli Atrash, Christopher Ferreri, Shonali Midha, Omar Nadeem, Omar Alexis Castaneda Puglianini, Kenneth Shain, Muhammad Bilal Abid, Peter Voorhees, Jack Khouri, Andrew Portuguese, Yi Lin, Surbhi Sidana, Doris Hansen, Krina Patel, Luciano Costa, Susan Bal, Larry Anderson
Abstract Number: abs25-7724
https://meetings-api.hematology.org/api/abstract/vmpreview/296369
Talquetamab outcomes in relapsed/refractory myeloma with extramedullary and paraskeletal soft tissue plasmacytomas
Aimaz Afrough, Oren Pasvolsky, Saurabh Zanwar, Mahmoud Gaballa, Aishwarya Sannareddy, Danai Dima, Utkarsh Goel, Hossam M. Ali, Kelley Julian, Andre Corraes, Raffaella Cassano, Murali Janakiram, Scott Goldsmith, James Davis, Kimberly Green, Noa Biran, Lindsay Fogel, Eli Zolotov, Megan Herr, Hamza Hassan, Leyla Shune, Jeries Kort, Susan Bal, Luciano Costa, J. Christine Ye, Laura Joiner, Shahzad Raza, Faiz Anwer, Jack Khouri, Rahul Banerjee, Andrew Portuguese, Surbhi Sidana, Masooma Rana, Lekha Mikkilineni, Hitomi Hosoya, Shebli Atrash, Christopher Ferreri, Cindy Varga, Douglas Sborov, Shonali Midha, Omar Nadeem, Ariel Grajales-Cruz, Rachid Baz, Brandon Blue, Ciara Louise Freeman, Frederick Locke, Krina Patel, Yi Lin, Shaji Kumar, Doris Hansen, Larry Anderson, Peter Voorhees, Omar Alexis Castaneda Puglianini
Abstract Number: abs25-7804
https://meetings-api.hematology.org/api/abstract/vmpreview/296449
Double-dose axicabtagene ciloleucel (Axi-Cel-2) as second-line therapy for high-risk relapsed or refractory large B-cell lymphoma (r/rLBCL): Interim results from a Phase 1b study
Dasom (Caroline) Lee, Kameron Rodrigues, Masooma Rana, Kendall Kozy, Sunny Salazar, Alexandria Jensen, Moksha Desai, Jayasindhu Mallampet, Claire Lohman, Ying-Wen Huang, Xiaoman Kang, Feng Tian, Jurik Mutter, Nick Phillips, Colleen Schweitzer, Faisal Cheema, Lekha Mikkilineni, Andrew Rezvani, Laura Johnston, Judith Shizuru, Everett Meyer, Robert Lowsky, Wen-Kai Weng, Melody Smith, Sushma Bharadwaj, Robert Negrin, Surbhi Sidana, Lori Muffly, Bita Sahaf, Yasodha Natkunam, Rhine Shen, Matthew Frank, Crystal Mackall, Zinaida Good, Ash Alizadeh, David Miklos, Saurabh Dahiya
Abstract Number: abs25-8384
https://meetings-api.hematology.org/api/abstract/vmpreview/297029
Rapcabtagene autoleucel (YTB323) for patients with first line high-risk large B-cell lymphoma: Phase II interim results
Jason Westin, Julio Chavez, Stephen J. Schuster, Vladan Vucinic, Patricia A. Young, Patrick Connor Johnson, Stefania Bramanti, Alessandro Rambaldi, Javier Briones Meijide, Koji Kato, Juan-Manuel Sancho, Mi Kwon, Carlos Solano, Shaun Fleming, Saurabh Dahiya, Alejandro Martin GarciaSancho, Pedro Marques Ramos, David Pearson, Salif Diallo, Aiesha Zia, Eduardo Segura, Aisha Masood, Pere Barba
Abstract Number: abs25-8917
https://meetings-api.hematology.org/api/abstract/vmpreview/297562
Validated PET-CT metabolic tumor volume threshold identifies high-risk relapsed/refractory LBCL and predicts 12-month toxicity-free progression-free survival Post–CAR-T therapy
Masooma Rana, Nima Ghalehsari, Alexandria Jensen, Dasom (Caroline) Lee, Natalie Park, Anmol Goyal, Ayesha Hashmi, William Wang, Eric Heng, Arash Velayati, Gaurav Dhapola, Ying-Wen Huang, Bita Sahaf, Wen-Kai Weng, Surbhi Sidana, Melody Smith, Sushma Bharadwaj, Matthew Frank, David Miklos, Michael Binkley, Saurabh Dahiya
Abstract Number: abs25-8956
https://meetings-api.hematology.org/api/abstract/vmpreview/297601
Long-term progression-free survival benefit with ciltacabtagene autoleucel in standard-risk relapsed / refractory multiple myeloma
Luciano Costa, Albert Oriol, Dominik Dytfeld, Salomon Manier, Peter Voorhees, Yi Lin, Myo Htut, Wilfried Roeloffzen, Phoebe Joy Ho, Urvi Shah, Man Zhao, Quanlin Li, Agnes Balogh, Katherine Li, Ana Slaughter, Nina Benachour, Carolina Lonardi, Arnab Ghosh, Huabin Sun, Nikoletta Lendvai, Tamar Lengil, Nitin Patel, Mythili Koneru, Erika Florendo, Octavio Costa, Vrinda Mahajan, Paula Rodriguez-Otero, Christopher Strouse, Keith Stewart, Surbhi Sidana
Abstract Number: abs25-9129
https://meetings-api.hematology.org/api/abstract/vmpreview/297774
Superior long-term outcomes with fludarabine and melphalan reduced intensity regimen in older AML/MDS patients undergoing allogeneic stem cell transplantation: An analysis of CIBMTR data
Piyanuch Kongtim, Andrew Portuguese, Soyoung Kim, Andrew Peterson, Hany Elmariah, Lori Muffly, Mark Juckett, Michael Grunwald, Mariam Nawas, Nelli Bejanyan, Tania Jain, Veronika Bachanova, Xia Bi, Ryan Stubbins, Wael Saber, Stefan Ciurea, Bart Scott
Abstract Number: abs25-9267
https://meetings-api.hematology.org/api/abstract/vmpreview/297912
Real-world outcomes of immune effector cell-associated hemophagocytic syndrome (IECHS) following ide-cel and cilta-cel therapy in relapsed/refractory multiple myeloma
Jerry Lee, Alexandria Jensen, Hitomi Hosoya, Aimaz Afrough, Saurabh Zanwar, Oren Pasvolsky, Mahmoud Gaballa, Christen Dillard, Jack Khouri, Shahzad Raza, Utkarsh Goel, Faiz Anwer, Vanna Hovanky, Masooma Rana, James Davis, Kimberly Green, Larry Anderson, Noa Biran, Eli Zolotov, Megan Herr, Hamza Hassan, Leyla Shune, Jeries Kort, Christopher Ferreri, Shebli Atrash, Cindy Varga, Peter Voorhees, Douglas Sborov, Gliceida Fortuna, Kelley Julian, Danai Dima, Andrew Portuguese, Rahul Banerjee, Ciara Louise Freeman, Karla Feliciano Salva, Raffaella Cassano Cassano, Lauren Peres, Brett Reid, Omar Alexis Castaneda Puglianini, Ariel Grajales-Cruz, Michael Jain, Krina Patel, Frederick Locke, Matthew Frank, Yi Lin, Doris Hansen, Surbhi Sidana, Nirali Shah, Lekha Mikkilineni
Abstract Number: abs25-10208
https://meetings-api.hematology.org/api/abstract/vmpreview/298853
Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study
Steven Siegel, Susan DeWolf, Joseph Schmalz, Nicholas Winn, James Kaminski, Stephanie Bien, Catherine Sanders, Harlan Robins, Jillian Zavistaski, Isabella Schichter, Lea Steinberg, Kristy Applegate, Merav Bar, Saurabh Chhabra, Sung Choi, William Clark, Suman Das, Robert Jenq, Richard Jones, John Levine, Brent Logan, Michael Martens, Hemant Murthy, Armin Rashidi, Marcie Riches, Wael Saber, Karamjeet Sandhu, Anthony Sung, Karilyn Larkin, Monzr M. Al Malki, Mahasweta Gooptu, Hany Elmariah, Amin Alousi, Lyndsey Runaas, Brian Shaffer, Andrew Rezvani, N El Jurdi, Alison Loren, Mary Horowitz, Mehdi Hamadani, Javier Bolanos-Meade, Shernan Holtan, Ami Bhatt, Miguel-Angel Perales, Leslie Kean
Abstract Number: abs25-10453
https://meetings-api.hematology.org/api/abstract/vmpreview/299098
Outcomes of bispecific T-cell engagers in MM patients with central nervous system (CNS) involvement
Mahmoud Gaballa, Lei Feng, Aimaz Afrough, Rahul Banerjee, James Davis, Azra Borogovac, Saurabh Zanwar, Kelley Julian, Noa Biran, Omar Alexis Castaneda Puglianini, Lekha Mikkilineni, Christopher Ferreri, Megan Herr, Leyla Shune, Evguenia Bhurtel, Danai Dima, Oren Pasvolsky, Kimberly Green, Murali Janakiram, Hamza Hassan, Nilesh Kalariya, Andre Corraes, Lindsay Fogel, Ruchi Singhal, Ariel Grajales-Cruz, Brandon Blue, Asad Haider, Aishwarya Sannareddy, Sherif Seif, Sheeba Thomas, Masooma Rana, J. Christine Ye, Tiffany Richards, Hitomi Hosoya, Shebli Atrash, Larry Anderson, Scott Goldsmith, Surbhi Sidana, Peter Voorhees, Douglas Sborov, Yi Lin, Andrew Portuguese, Doris Hansen, Krina Patel
Abstract Number: abs25-10464
https://meetings-api.hematology.org/api/abstract/vmpreview/299109
Rapid peak CAR-T expansion is associated with delayed neurotoxicity following ciltacabtagene autoleucel in multiple myeloma
Hitomi Hosoya, Arash Velayati, Danai Dima, Alexandria Jensen, Andrew Portuguese, Vanna Hovanky, Lekha Mikkilineni, Lauren Peres, Sylvester Homsy, Masooma Rana, Juancarlos Cancilla, Zachary Ehlinger, Bita Sahaf, Theresa Latchford, Ciara Louise Freeman, Omar Alexis Castaneda Puglianini, Saurabh Dahiya, Frederick Locke, David Miklos, Rahul Banerjee, Doris Hansen, Melissa Alsina, Surbhi Sidana
Abstract Number: abs25-11936
https://meetings-api.hematology.org/api/abstract/vmpreview/300581
Superior efficacy and persistence of Orca-T-allogeneic CAR19/22 versus autologous CAR19/22 in high-risk adult B-ALL
Alfonso Molina, Parveen Shiraz, Alyssa Kanegai, Ayesha Fraser, Diana Kordek, Caroline Wagner, Hrishikesh Srinagesh, Lindsay Danley, Arvind Ramakrishnan, Hossein Daghagh, Ying-Wen Huang, Gaurav Dhapola, Aman Siddiqui, Sally Arai, Sushma Bharadwaj, Saurabh Dahiya, Hany Elmariah, Matthew Frank, Hitomi Hosoya, Vanessa Kennedy, Laura Johnston, Everett Meyer, Lekha Mikkilineni, Robert Lowsky, Robert Negrin, Andrew Rezvani, Judith Shizuru, Surbhi Sidana, Wen-Kai Weng, Catherine McIntyre, Steven Feldman, Bita Sahaf, Crystal Mackall, David Miklos, Lori Muffly, Melody Smih
Abstract Number: abs25-11967
https://meetings-api.hematology.org/api/abstract/vmpreview/300612
CD22-CAR T cell multiomic features linked to patient outcomes in CD19-CAR resistant large B cell lymphoma
Anne Marijn Kramer, Tara Murty, Yiyun Chen, Kameron Rodrigues, Mark Hamilton, Moksha Desai, Adam Kuo, Zachary Ehlinger, Warren Reynolds, Hrishikesh Srinagesh, Kristin Tsui, Skyler Rietberg, Kelvin Mo, John Baird, Yi-Jiun Su, Neha Agarwal, Elena Sotillo, Snehit Prabhu, Bita Sahaf, Saurabh Dahiya, Sneha Ramakrishna, Lori Muffly, Crystal Mackall, David Miklos, Zinaida Good, Matthew Frank
Abstract Number: abs25-12096
https://meetings-api.hematology.org/api/abstract/vmpreview/300741
FOXP3 and helios expressing CD4+ T conventional cells are a regulatory-like subset that is induced after orca-T allogeneic immunotherapy
Cameron Bader, Scott Killian, Bettina Iliopoulou, Pin-I Chen, Shiva Pathak, Xuhuai Ji, Nate Fernhoff, Kent Jensen, Robert Negrin, Everett Meyer
Abstract Number: abs25-12118
https://meetings-api.hematology.org/api/abstract/vmpreview/300763
Allogeneic HSC and regulatory T cell (Orca-T) engineered cell therapy following reduced intensity conditioning: Results of a single center Phase 1 study
Alejandro Villar-Prados, Paige Kim, Katherine Sutherland, Robert Negrin, Sally Arai, Matthew Frank, Laura Johnston, Robert Lowsky, David Miklos, Lori Muffly, Saurabh Dahiya, Andrew Rezvani, Surbhi Sidana, Parveen Shiraz, Judith Shizuru, Wen-Kai Weng, Melody Smith, Sushma Bharadwaj, John Tamaresis, Anna Pavlova, J. Scott McClellan, Everett Meyer
Abstract Number: abs25-12569
https://meetings-api.hematology.org/api/abstract/vmpreview/301214
Talquetamab for relapsed/refractory multiple myeloma : Real-world outcomes from the US multiple myeloma immunotherapy consortium
Oren Pasvolsky, Ariel Grajales-Cruz, Doris Hansen, Lei Feng, Danai Dima, Aimaz Afrough, Kenneth Shain, Rahul Banerjee, Saurabh Zanwar, Faiz Anwer, Hitomi Hosoya, James Davis, Aishwarya Sannareddy, Lisa Lee, Jing Christine Ye, Omar Alexis Castaneda Puglianini, Karun Neupane, Tiffany Richards, Amrita Krishnan, Noa Biran, Megan Herr, Shahzad Raza, Leyla Shune, Susan Bal, Lindsay Fogel, Masooma Rana, Hamza Hassan, Hossam M. Ali, Rachid Baz, Laura Joiner, Christopher Ferreri, Kimberly Green, Murali Janakiram, Cindy Varga, Gliceida Galarza Fortuna, Mahmoud Gaballa, Kelley Julian, Lekha Mikkilineni, Evguenia Bhurtel, Shebli Atrash, Eli Zolotov, Douglas Sborov, Peter Voorhees, Utkarsh Goel, Larry Anderson, Andrew Portuguese, Hans Lee, Jack Khouri, Surbhi Sidana, Luciano Costa, Krina Patel, Yi Lin
Abstract Number: abs25-12771
https://meetings-api.hematology.org/api/abstract/vmpreview/301416
Association between cilta-cel dose and efficacy and toxicity outcomes for patients with Relapsed/Refractory multiple myeloma (RRMM): A real-world analysis from the US multiple myeloma immunotherapy consortium
Ran Reshef, Alexandria Jensen, Christian Gordillo, Brett Reid, Danai Dima, Lauren Peres, Mahmoud Gaballa, Rahul Banerjee, Oren Pasvolsky, Aimaz Afrough, Christen Dillard, Christopher Ferreri, Shebli Atrash, Cindy Varga, Andrew Portuguese, Masooma Rana, Hitomi Hosoya, Lekha Mikkilineni, Vanna Hovanky, Saurabh Zanwar, Nilesh Kalariya, Damian Mikulski, Charlotte Wagner, Christopher Cahoon, Omar Puglianini, Gabriel De Avila, Eli Zolotov, Evguenia Bhurtel, Ariel Grajales-Cruz, Utkarsh Goel, Aishwarya Sannareddy, Jeries Kort, Raffaella Cassano, Shonali Midha, James Davis, Rebecca Gonzalez, Megan Herr, Zhuoer Xie, Hamza Hassan, Sneha Purvey, Marcus Geer, Kimberly Green, Fabiana Perna, Hien Liu, Taiga Nishihori, Jack Khouri, Shahzad Raza, Faiz Anwer, Susan Bal, Omar Nadeem, Ciara Louise Freeman, Leyla Shune, Kenneth Shain, Melissa Alsina, Rachid Baz, Douglas Sborov, Saurabh Dahiya, Frederick Locke, David Miklos, Peter Voorhees, Larry Anderson, Luciano Costa, Noa Biran, Shaji Kumar, Yi Lin, Krina Patel, Doris Hansen, Surbhi Sidana
Abstract Number: abs25-13483
https://meetings-api.hematology.org/api/abstract/vmpreview/302128
Preliminary safety and efficacy of myeloablative orca-q with tacrolimus or without graft-versus-host disease prophylaxis for treatment of advanced hematologic malignancies
Samer Srour, Mehrdad Abedi, Amandeep Salhotra, Edmund Waller, Hannah Choe, Anna Pavlova, Tamara Zharkevich, Scott Killian, J. Scott McClellan, Nate Fernhoff, Robert Lowsky
Abstract Number: abs25-13739
https://meetings-api.hematology.org/api/abstract/vmpreview/302384
Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506
Sameem Abedin, Victor Baidoo, Aniko Szabo, Richard Jones, Anurag Singh, Mark Litzow, John Wingard, Esperanza Papadopoulos, Alexander Perl, Robert Soiffer, Celalettin Ustun, Masumi Ueda Oshima, Geoffrey Uy, Edmund Waller, Sumithira Vasu, Melhem Solh, Asmita Mishra, Lori Muffly, Heeje Kim, Matthias Stelljes, Yuho Najima, Masahiro Onozawa, Caroline Chen, Nahla Hasabou, Mathew Rosales, Jason Hill, Stanley Gill, Rishita Nuthethi, Denise King, Adam Mendizabal, Steven Devine, Mary Horowitz, Yi-Bin Chen, Mark Levis, Mehdi Hamadani
Abstract Number: abs25-13778
https://meetings-api.hematology.org/api/abstract/vmpreview/302423
Multi-omic single cell sequencing reveals discordant MRD and mechanisms of relapse in pediatric AML
Cheryl Peretz, Natalia Murad, Rula Gladden, Anushka Walia, Andrew Koh, Elaine Tran, Vanessa Kennedy, Shruti Bhise, Everett Fan, Rhonda Ries, Benjamin Huang, Soheil Meshinchi, Adam Olshen, Scott Furlan, Catherine Smith
Abstract Number: abs25-14724
https://meetings-api.hematology.org/api/abstract/vmpreview/303369
Redefining post-CD19 CAR T-cell surveillance with ctdna: Real-world insights from postaxi-cel and liso-cel therapy
Snegha Ananth, Jayasindhu Mallampet, Betty Chang, Neha Agarwal, Katherine Kong, Bita Sahaf, Juan Carlos Suarez Serrato, Ilan Kirsch, Allison Jacob, Heidi Simmons, Lik Wee Lee, Crystal Mackall, Wen-Kai Weng, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, David Miklos, Matthew Frank
Abstract Number: abs25-14738
https://meetings-api.hematology.org/api/abstract/vmpreview/303383
Predictors of early relapse following ciltacabtagene autoleucel: Informing risk-adapted therapy in relapsed/refractory multiple myeloma
Doris Hansen, Lauren Peres, Danai Dima, Saurabh Zanwar, Omar Alexis Castaneda Puglianini, Alicia Richards, Mahmoud Gaballa, Oren Pasvolsky, Aimaz Afrough, Brett Reid, Ariel Grajales-Cruz, Zhuoer Xie, Utkarsh Goel, Aishwarya Sannareddy, Christen Dillard, Christopher Ferreri, Shebli Atrash, Cindy Varga, Andrew Portuguese, Hitomi Hosoya, Lekha Mikkilineni, Nilesh Kalariya, Damian Mikulski, Charlotte Wagner, Christopher Cahoon, Peter Cheng, Christian Gordillo, Eli Zolotov, Evguenia Bhurtel, Jeries Kort, Raffaella Cassano Cassano, Shonali Midha, James Davis, Rebecca Gonzalez, Megan Herr, Hamza Hassan, Sneha Purvey, Marcus Geer, Kimberly Green, Fabiana Perna, Hien Liu, Taiga Nishihori, Jack Khouri, Shahzad Raza, Faiz Anwer, Susan Bal, Omar Nadeem, Ciara Louise Freeman, Rahul Banerjee, Leyla Shune, Ran Reshef, Kenneth Shain, Melissa Alsina, Rachid Baz, Douglas Sborov, Peter Voorhees, Larry Anderson, Luciano Costa, Noa Biran, Shaji Kumar, Frederick Locke, Yi Lin, Surbhi Sidana, Krina Patel
Abstract Number: abs25-15365
https://meetings-api.hematology.org/api/abstract/vmpreview/304010
Pre-treatment CD19 antigen density and multi-antigen profiling by calibrated quantitative flow cytometry correlates with CAR T efficacy in LBCL
Jay Spiegel, Jean Oak, Masooma Rana, Alexandria Jensen, Dasom (Caroline) Lee, Sao-Mai NguyenMau, Katherine Kong, Scott Bornheimer, Lekha Mikkilineni, Lori Muffly, Surbhi Sidana, Wen-Kai Weng, Sushma Bharadwaj, Melody Smith, Matthew Frank, Rhine Shen, Crystal Mackall, Yasodha Natkunam, David Miklos, Saurabh Dahiya
Abstract Number: abs25-7716
https://meetings-api.hematology.org/api/abstract/vmpreview/296361
CD22-directed CAR-T cells induce complete remissions in high-risk follicular and Mantle Cell Lymphoma with limited neurotoxicity
Hrishikesh Srinagesh, Anne Marijn Kramer, Mark Hamilton, Yi-Jiun Su, Kendall Kozy, LaTesha Jackson, Annie Brown, Kimi DeNoble, Sharon Mavroukakis, Claire Lohman, Kristen Cunanan, Neha Agarwal, Sushma Bharadwaj, Warren Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert Negrin, Andrew Rezvani, Judith Shizuru, Lekha Mikkilineni, Hitomi Hosoya, Parveen Shiraz, Surbhi Sidana, Wen-Kai Weng, Vanessa Kennedy, Melody Smith, Saurabh Dahiya, Kara Davis, Sneha Ramakrishna, Liora Schultz, Ramya Tunuguntla, Lori Muffly, Crystal Mackall, David Miklos, Matthew Frank
Abstract Number: abs25-10292
https://meetings-api.hematology.org/api/abstract/vmpreview/298937
Post-transplant cyclophosphamide vs tacrolimus/methotrexate: Improved GRFS, reduced NRM, and less severe GVHD in myeloablative HLA-matched allogeneic transplantation
Alfonso Molina, Quenton Bubb, Ryan Yee, Sally Arai, Sushma Bharadwaj, Saurabh Dahiya, Hany Elmariah, Matthew Frank, Hitomi Hosoya, Laura Johnston, Everett Meyer, Lekha Mikkilineni, Robert Lowsky, Robert Negrin, Andrew Rezvani, Judith Shizuru, Surbhi Sidana, Melody Smith, Wen-Kai Weng, David Miklos, Lori Muffly, Vanessa Kennedy
Abstract Number: abs25-10437
https://meetings-api.hematology.org/api/abstract/vmpreview/299082
Patients with TP53-mutated AML/MDS without complex or monosomal karyotype can achieve durable survival benefits with allogeneic HCT
Nikeshan Jeyakumar, Nancy Torres, Suneeta Godbole, Fiona Yamamoto, Bing Zhang, Sally Arai, Sushma Bharadwaj, Saurabh Dahiya, Hany Elmariah, Matthew Frank, Hitomi Hosoya, Laura Johnston, Everett Meyer, Lekha Mikkilineni, Robert Lowsky, Robert Negrin, Andrew Rezvani, Judith Shizuru, Surbhi Sidana, Melody Smith, Wen-Kai Weng, David Miklos, Matthew Schwede, Gabriel Mannis, Tian Zhang, Lori Muffly, Vanessa Kennedy
Abstract Number: abs25-10576
https://meetings-api.hematology.org/api/abstract/vmpreview/299221
Non-response to bridging therapy prior to CAR-T is associated with increased toxicity and adverse outcomes in Relapsed/Refractory multiple myeloma (RRMM)
Masooma Rana, Alexandria Jensen, Arash Velayati, Vanna Hovanky, Lori Muffly, Bita Sahaf, David Iberri, Michaela Liedtke, Sushma Bharadwaj, Vanessa Kennedy, Sally Arai, Parveen Shiraz, Wen-Kai Weng, Melody Smith, Matthew Frank, David Miklos, Saurabh Dahiya, Hitomi Hosoya, Lekha Mikkilineni, Surbhi Sidana
Abstract Number: abs25-10697
https://meetings-api.hematology.org/api/abstract/vmpreview/299342
From response to rupture: Evaluating GI perforation after CD19 CAR‑T in LBCL
Arash Velayati, Masooma Rana, Alexandria Jensen, Dasom (Caroline) Lee, Nima Ghalehsari, Anmol Goyal, Theresa Latchford, William Wang, Eric Heng, Wen-Kai Weng, Melody Smith, Sushma Bharadwaj, Matthew Frank, David Miklos, Saurabh Dahiya
Abstract Number: abs25-14430
https://meetings-api.hematology.org/api/abstract/vmpreview/303075
Real-world comparison of progression-free and overall survival between idecabtagene vicleucel (ide-cel) and teclistamab in triple-class exposed relapsed/refractory multiple myeloma
Krina Patel, Jenny Chen, Devender Dhanda, Kevin Towle, Luciano Costa, Sikander Ailawadhi, Saad Usmani, Sridevi Rajeeve, Yi Lin, Sichen Liu, Shannon Cope, Surbhi Sidana
Abstract Number: abs25-1764
https://meetings-api.hematology.org/api/abstract/vmpreview/290409
Two-year update of ZUMA-2 Cohort 3: Brexucabtagene autoleucel (Brexu-cel) in patients (pts) with relapsed/refractory mantle cell lymphoma (R/R MCL) who had not received prior Bruton tyrosine kinase inhibitor (BTKi) therapy
Tom Van Meerten, Marie José Kersten, Gloria Iacoboni, Georg Hess, Pim Mutsaers, Alejandro Martin Garcia-Sancho, Andre Goy, Eva Gine, Brian Hill, Wen-Kai Weng, Martin Dreyling, Patrick Reagan, Krish Patel, Ahmed Galal, Charles Herbaux, Robin Sanderson, Dan Zheng, Sabina Adhikary, Wangshu Zhang, Rita Damico Khalid, Ioana Kloos, Michael Wang
Abstract Number: abs25-2240
https://meetings-api.hematology.org/api/abstract/vmpreview/290885
Real-world effectiveness and safety outcomes by age, comorbidity, frailty, and treatments prior to infusion in relapsed or refractory (R/R) follicular lymphoma patients treated with axicabtagene ciloleucel
Aung Tun, Matthew Frank, Madiha Iqbal, Alex Herrera, Mehdi Hamadani, Waleska Pérez, Soyoung Kim, Babatunde Adedokun, Constance Lau, Kenny Hu, Timothy Best, Olga Nikolajeva, Grace Lee, Marcelo Pasquini, Caron Jacobson
Abstract Number: abs25-2686
https://meetings-api.hematology.org/api/abstract/vmpreview/291331
The real-world safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy in systemic AL amyloidosis
Matthew Rees, Raffaella Cassano Cassano, Melinda Tan, Eli Zolotov, Surbhi Sidana, Danai Dima, Jeries Kort, Aimaz Afrough, Mahmoud Gaballa, Oren Pasvolsky, Lekha Mikkilineni, Jack Khouri, Shahzad Raza, Saurabh Zanwar, Christopher Ferreri, Adeel Khan, Shebli Atrash, Andrew Portuguese, Vanna Hovanky, Rahul Banerjee, Ciara Louise Freeman, Krina Patel, Larry Anderson, Omar Alexis Castaneda Puglianini, Leyla Shune, Noa Biran, Doris Hansen, Yi Lin
Abstract Number: abs25-2732
https://meetings-api.hematology.org/api/abstract/vmpreview/291377
The real-world safety and efficacy of bispecific t-cell engager therapy in systemic AL amyloidosis
Matthew Rees, Jack Khouri, Ariel Grajales-Cruz, Saurabh Zanwar, Utkarsh Goel, Shonali Midha, Kelley Julian, Omar Alexis Castaneda Puglianini, Andre De Menezes Silva Corraes, Shahzad Raza, James Davis, Kimberly Green, Doris Hansen, Rahul Banerjee, Surbhi Sidana, Krina Patel, Giada Bianchi, Douglas Sborov, Sarah Lee, Rachid Baz, Faiz Anwer, Lekha Mikkilineni, Omar Nadeem, Yi Lin, Larry Anderson
Abstract Number: abs25-2734
https://meetings-api.hematology.org/api/abstract/vmpreview/291379
Patient characteristics, toxicity, and response after real world administration of obecabtagene autoleucel and brexucabtagene autoleucel for relapsed acute lymphoblastic leukemia: A rocca analysis
Yannis Valtis, Karamjeet Sandhu, Rawan Faramand, Amy Zhang, Katharine Miller, LaQuisa Hill, Ibrahim Muhsen, Tamer Othman, Marlise Luskin, Evan Chen, Caspian Oliai, Georgia Lill, Ryan Cassaday, Noam Kopmar, Aaron Logan, Matthew Connor, Talal Hilal, Jae Park, Melhem Solh, Caitlin Guzowski, Jessica Leonard, Virginia Tan, Nikeshan Jeyakumar, Hrishikesh Srinagesh, Muthu Kumaran, Rasmus Hoeg, Divya Koura, Kaitlyn Dykes, Wendy Stock, Vivian Irizarry Gatell, Clayton Jackson, Olalekan Oluwole, Bhagirathbhai Dholaria, Kristen O'Dwyer, Jozal Moore, Matthew Ulrickson, Ali Al-Darobi, Ken Byrd, Stephanie Tsai, Timothy O'Connor, Eunice Wang, Ross McCauley, Omer Jamy, Razan Mohty, Gregory Roloff, Katherine Sutherland, Ibrahim Aldoss, Bijal Shah, Lori Muffly, Noelle Frey
Abstract Number: abs25-4004
https://meetings-api.hematology.org/api/abstract/vmpreview/292649
Evaluation of commercially available chimeric antigen receptor (CAR) detection reagents for monitoring of CAR T-cell (CAR T) expansion and persistence in patients (pts) treated with obecabtagene autoleucel (obe-cel)
Rehan Hussain, Yousef Farag, Anish Patel, Hrishikesh Srinagesh, Lori Muffly, Bita Sahaf, David Miklos, Mathieu Ferrari, William Day, Pierre Lao-Sirieix
Abstract Number: abs25-4031
https://meetings-api.hematology.org/api/abstract/vmpreview/292676
Incidence and risk factors for CNS relapse in adult ALL after allogeneic hematopoietic cell transplant
Catherine Le, Amy Zhang, Rutu Vyas, Joanne Otani, Katie Russell, Ryan D Cassaday, Lori Muffly, Emily Liang
Abstract Number: abs25-4307
https://meetings-api.hematology.org/api/abstract/vmpreview/292952
Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution. Results from the BMT CTN 1801 study
Kayleigh Ingersoll Omdahl, Steven Siegel, Jiayi Dong, Susan DeWolf, Kyle Hebert, Donna Neuberg, Isabella Schichter, Alexandre Albanese, Paul Keskula, Lorenzo Cagnin, Kristy Applegate, Merav Bar, Saurabh Chhabra, Sung Choi, William Clark, Suman Das, Robert Jenq, Richard Jones, John Levine, Brent Logan, Michael Martens, Hemant Murthy, Armin Rashidi, Marcie Riches, Wael Saber, Karamjeet Sandhu, Anthony Sung, Karilyn Larkin, Monzr M. Al Malki, Mahasweta Gooptu, Hany Elmariah, Amin Alousi, Lyndsey Runaas, Brian Shaffer, Andrew Rezvani, Najla El Jurdi, Alison Loren, Mary Horowitz, Javier Bolanos-Meade, Shernan Holtan, Ami Bhatt, Miguel-Angel Perales, Leslie Kean
Abstract Number: abs25-7675
https://meetings-api.hematology.org/api/abstract/vmpreview/296320
Phase II Study of post transplant cyclophosphamide-based graft versus host disease prophylaxis after HLA-mismatched unrelated donor transplantation and reduced intensity conditioning: Results from the NMDP-sponsored access expansion Study
Mahasweta Gooptu, Monzr M. Al Malki, Stephanie Bo-Subait, Brent Logan, Erin Leckrone, Sarah Smith, Heather Stefanski, Jeffery Auletta, Stephen Spellman, Craig Malmberg, Medhat Askar, Rachel Cusatis, Farhad Khimani, Dipenkumar Modi, Mehdi Hamadani, Martin Maiers, Joseph Stanek, Javier Meade, Uttam Rao, Jordan Milner, Ramzi Abboud, Katarzyna Jamieson, George Carrum, Bhagirathbhai Dholaria, William Hogan, Ran Reshef, Satyajit Kosuri, Rachel Cook, Karen Ballen, Alison Loren, Karilyn Larkin, Sally Arai, Muna Qayed, Sung Choi, Larisa Broglie, Bronwen Shaw, Steven Devine, Antonio Jimenez Jimenez, Brian Shaffer
Abstract Number: abs25-7723
https://meetings-api.hematology.org/api/abstract/vmpreview/296368
Sequential CD19 and CD22 CART for relapsed and refractory B cell ALL: Phase I results
Liora Schultz, Catherine Aftandilian, Christina Baggott, Nicole Corwin, Michelle Fujimoto, Amy Li, Sharon Mavroukakis, Jennifer Moon, Bita Sahaf, Ashley Jacobs, Emily DeYager, Cristina Mendoza, Andrea Levenson, Matthew Frank, David Miklos, Lori Muffly, Steven Feldman, Janette Alcazar, Ramya Tunuguntla, Annie Brown, Raya Saab, Jay Balagtas, Tanja Gruber, Pablo Domizi, Sneha Ramakrishna, Crystal Mackall, Kara Davis
Abstract Number: abs25-8243
https://meetings-api.hematology.org/api/abstract/vmpreview/296888
Comparative efficacy of ciltacabtagene autoleucel (cilta-cel) versus belantamab mafodotin (belamaf), bortezomib, and dexamethasone and versus belamaf, pomalidomide, and dexamethasone in patients with relapsed / refractory multiple myeloma (RRMM) previously treated with 1–3 prior lines of therapy using a matching-adjusted indirect comparison
Christopher Strouse, Surbhi Sidana, Rafael Fonseca, Joaquin Martinez-Lopez, Yaël Cohen, Binod Dhakal, Murali Janakiram, Suzy Van Sanden, João Mendes, Joris Diels, Seina Lee, Sundar Jagannath
Abstract Number: abs25-8811
https://meetings-api.hematology.org/api/abstract/vmpreview/297456
Identifying high-risk profiles and adverse prognoses in relapsed/refractory multiple myeloma treated with bispecific antibodies: A real-world analysis of 943 treatment initiations
Saurabh Zanwar, Oren Pasvolsky, Doris Hansen, Utkarsh Goel, Aimaz Afrough, Masooma Rana, Andrew Portuguese, James Davis, Douglas Sborov, Susan Bal, Murali Janakiram, Leyla Shune, Christopher Ferreri, Noa Biran, Megan Herr, Hamza Hassan, Ariel Grajales-Cruz, Jack Khouri, Andre De Menezes Silva Corraes, Jeries Kort, Shebli Atrash, Omar Puglianini, Rachid Baz, Raffaella Cassano Cassano, Emily Liang, Eli Zolotov, Hossam M. Ali, Cindy Varga, Tiffany Richards, Hitomi Hosoya, Mahmoud Gaballa, Christen Dillard, Gliceida Galarza Fortuna, Lisa Lee, Kelley Julian, Kimberly Green, Aishwarya Sannareddy, Larry Anderson, Melissa Alsina, Shahzad Raza, Danai Dima, Lekha Mikkilineni, Faiz Anwer, Rahul Banerjee, Amrita Krishnan, Frederick Locke, Peter Voorhees, Shaji Kumar, Surbhi Sidana, Krina Patel, Binod Dhakal, Yi Lin, Luciano Costa
Abstract Number: abs25-8860
https://meetings-api.hematology.org/api/abstract/vmpreview/297505
Real-world outcomes with blinatumomab as a bridging therapy for allogeneic hematopoietic stem cell transplantation in relapsed/refractory or measurable residual disease-positive Bcell acute lymphoblastic leukemia: A CIBMTR database analysis
Wael Saber, Ruta Brazauskas, Jinalben Patel, Mona Patel, Lori Muffly, Mark Juckett, Michael Grunwald, Nelli Bejanyan, Tania Jain, Veronika Bachanova, Heejoo Jo, Biyao Zou, Jessica Choudhry, Yi Zeng
Abstract Number: abs25-8980
https://meetings-api.hematology.org/api/abstract/vmpreview/297625
Predictors of outcomes to allogeneic hematopoietic cell transplantation (allo-HCT) for TP53 mutant myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML) patients and impact of hypomethylating agent (HMA) maintenance therapy
Caroline Wagstaff, Asmita Mishra, Amy McLemore, Onyee Chan, Rory Shallis, Joseph Pidala, Andrew Kuykendall, Samuel Reynolds, Hany Elmariah, Najla Al Ali, Nancy Torres, Zhuoer Xie, Lia Perez, Rawan Faramand, Alison Walker, Taiga Nishihori, Eric Padron, Jeffrey Lancet, Nelli Bejanyan, Rami Komrokji, David Sallman
Abstract Number: abs25-8999
https://meetings-api.hematology.org/api/abstract/vmpreview/297644
Off-the-shelf CD117 CAR-iNKT cells as a safe and effective allogeneic immunotherapy targeting AML and its immunosuppressive microenvironment
Hao Yan, Chaiyaporn Boonchalermvichian, Biki Gupta, Jeanette Baker, Jiayan Zhou, Sisi Wang, Cameron Bader, Federico Simonetta, Robert Negrin
Abstract Number: abs25-9569
https://meetings-api.hematology.org/api/abstract/vmpreview/298214
Subsequent primary malignancies after CAR-T therapy: A study from the US multiple myeloma immunotherapy consortium
Eli Zolotov, Noa Biran, Patrick Roney, Jaeil Ahn, Matthew Rees, Rahul Banerjee, Melinda Tan, Surbhi Sidana, Danai Dima, Shaun DeJarnette, Aimaz Afrough, Mahmoud Gaballa, Oren Pasvolsky, Jack Khouri, Shahzad Raza, Utkarsh Goel, Faiz Anwer, Saurabh Zanwar, Yi Lin, Shebli Atrash, Ran Reshef, Christian Gordillo, Andrew Portuguese, Raffaella Cassano Cassano, Evguenia Bhurtel, Jeries Kort, Leyla Shune, Marcus Geer, Zhuoer Xie, Omar Alexis Castaneda Puglianini, Doris Hansen, Ciara Louise Freeman, Frederick Locke, Taiga Nishihori, Ariel Grajales-Cruz, James Davis, Kimberly Green, Megan Herr, Hamza Hassan, Lekha Mikkilineni, Hitomi Hosoya, Aishwarya Sannareddy, Krina Patel, Larry Anderson, Adeel Khan, Douglas Sborov, Charlotte Wagner, Christopher Cahoon, Gliceida Galarza Fortuna, Sneha Purvey, Christopher Ferreri
Abstract Number: abs25-9601
https://meetings-api.hematology.org/api/abstract/vmpreview/298246
KMT2Ar, but not other high-risk genetics, adversely impacts outcomes in adult patients with relapsed/refractory (R/R) Philadelphia chromosome negative B-cell acute lymphoblastic leukemia (BALL) treated with brexucabtagene autoleucel (Brexu-cel)
Jessica Leonard, Abdullah Ladha, Rawan Faramand, Gregory Roloff, Yannis Valtis, Virginia Tan, Katharine Miller, Amy Zhang, Michael Grunwald, Vamsi Kota, Jacob Boccucci, Matthew Ulrickson, Ali Al-Darobi, LaQuisa Hill, Ibrahim Muhsen, Joshua Sasine, Anjali Advani, Karamjeet Sandhu, Ran Reshef, Marlise Luskin, Evan Chen, Chenyu Lin, Ryan Cassaday, Noam Kopmar, Melhem Solh, Catherine Lee, Silvina Odstrcil Bobillo, Stephanie Tsai, Timothy O'Connor, Talal Hilal, Jae Park, Sumithira Vasu, Evandro Bezerra, Kristen O'Dwyer, Jozal Moore, Eunice Wang, Ross McCauley, Navneet Majhail, Aravind Ramakrishnan, Luke Mountjoy, Shahbaz Malik, Minoo Battiwalla, Paul Shaughnessy, John Mathews, Hrishikesh Srinagesh, Katherine Sutherland, Omer Jamy, Razan Mohty, Muthu Kumaran, Rasmus Hoeg, Caspian Oliai, Georgia Lill, Wendy Stock, Marc Schwartz, Tamer Othman, Divya Koura, Kaitlyn Dykes, Aaron Logan, Michael Daunov, Ken Byrd, Fevzi Yalniz, Veronika Bachanova, Sean Tracy, Punita Grover, Matthew Connor, George Yaghmour, Vivian Irizarry Gatell, Clayton Jackson, Olalekan Oluwole, Bhagirathbhai Dholaria, Noelle Frey, Lori Muffly, Bijal Shah, Ibrahim Aldoss
Abstract Number: abs25-9683
https://meetings-api.hematology.org/api/abstract/vmpreview/298328
Inhibition of DRP1–FIS1–Mediated mitochondrial fission as a novel strategy to prevent gvhd
Hao Yan, Vijith Vijayan, Chun-Hsien Chiang, Xiaobin Zheng, Ivan Lopez, Kaylin Prentiss, Jeanette Baker, Daria Mochly-Rosen, Robert Negrin, Kenneth Weinberg, Bereketeab Haileselassie
Abstract Number: abs25-9780
https://meetings-api.hematology.org/api/abstract/vmpreview/298425
Identifying candidates for outpatient administration of ciltacabtagene autoleucel (Cilta-cel) in relapsed-refractory multiple myeloma (RRMM)
Danai Dima, Lauren Peres, Leyla Shune, Christelle Leitzinger, Brett Reid, Andrew Portuguese, Raffaella Cassano Cassano, Rahul Banerjee, Nilesh Kalariya, Oren Pasvolsky, Mahmoud Gaballa, Zachary Hunzeker, Christen Dillard, Hitomi Hosoya, Lekha Mikkilineni, Rebecca Gonzalez, Ariel Grajales-Cruz, Omar Alexis Castaneda Puglianini, Taiga Nishihori, Charlotte Wagner, Christopher Cahoon, Douglas Sborov, Evguenia Bhurtel, Jeries Kort, Marcus Geer, Sneha Purvey, Christopher Ferreri, Cindy Varga, Shebli Atrash, Peter Voorhees, Utkarsh Goel, Jack Khouri, Shahzad Raza, Faiz Anwer, Aimaz Afrough, Aishwarya Sannareddy, Larry Anderson, Hamza Hassan, Megan Herr, Ran Reshef, Christian Gordillo, Eli Zolotov, Noa Biran, James Davis, Kimberly Green, Saurabh Zanwar, Yi Lin, Luciano Costa, Susan Bal, Shonali Midha, Omar Nadeem, Melissa Alsina, Rachid Baz, Kenneth Shain, Frederick Locke, Shaji Kumar, Krina Patel, Surbhi Sidana, Doris Hansen
Abstract Number: abs25-10729
https://meetings-api.hematology.org/api/abstract/vmpreview/299374
Hematopoietic stem cell transplantation using briquilimab (Anti-CD117 Antibody-Conditioning), immunosuppression and TCRαβ+ T-cell/CD19+ B-cell depleted haploidentical grafts in patients with fanconi anemia: An approach without irradiation, busulfan and calcineurin inhibitors.
Rajni Agarwal, Alice Bertaina, Charmaine Soco, Janel Long-Boyle, Gopin Saini, Nivedita Kunte, Lyndsie Hiroshima, Yan Yi Chan, Hana Willner, Mark Krampf, Maite Van Hentenryck, Rhonda Perriman, Elena Istomina, Giulia Barbarito, Amelia Scheck, Hena Din, Edna Klinger, Jerry Cheng, Marcin Wlodarski, Jaap Jan Boelens, Judith Shizuru, Wendy Pang, Kenneth Weinberg, Robertson Parkman, Maria-Grazia Roncarolo, Matthew Porteus, Agnieszka Czechowicz
Abstract Number: abs25-11879
https://meetings-api.hematology.org/api/abstract/vmpreview/300524
Attention-based multiple instance learning predicts CAR T cell therapy outcomes from infusion product single-cell RNA-seq data and identifies engineering targets in large B cell lymphoma
Kameron Rodrigues, Kristin Tsui, Xianghao Zhan, Yiyun Chen, Kelvin Mo, Crystal Mackall, David Miklos, Gevaert, Zinaida Good
Abstract Number: abs25-12164
https://meetings-api.hematology.org/api/abstract/vmpreview/300809
Real-world effectiveness and safety outcomes by age, comorbidities, and frailty among relapsed or refractory (R/R) Mantle Cell Lymphoma (MCL) patients treated with brexucabtagene autoleucel (brexu-cel)
Amer Beitinjaneh, Supriya Gupta, Fateeha Furqan, John Baird, Wen-Kai Weng, Caron Jacobson, Soyoung Kim, Zhongyu Feng, Babatunde Adedokun, Jiali Yan, Qian Huang, Kenny Hu, Timothy Best, Ioana Kloos, Grace Lee, Mehdi Hamadani, Marcelo Pasquini, Frederick Locke
Abstract Number: abs25-13334
https://meetings-api.hematology.org/api/abstract/vmpreview/301979
CRS/ICANS Prophylaxis does not Improve Outcomes in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (B-ALL) treated with brexucabtagene autoleucel
Ross McCauley, Amy Zhang, Vamsi Kota, Jacob Boccucci, Michael Grunwald, Matthew Ulrickson, LaQuisa Hill, Ibrahim Muhsen, Joshua Sasine, Anjali Advani, Ibrahim Aldoss, Karamjeet Sandhu, Ran Reshef, Marlise Luskin, Chenyu Lin, Ryan Cassaday, Noam Kopmar, Melhem Solh, Silvina Odstrcil Bobillo, Stephanie Tsai, Talal Hilal, Bijal Shah, Rawan Faramand, Jae Park, Yannis Valtis, Tamer Othman, Sumithira Vasu, Evandro Bezerra, Jessica Leonard, Virginia Tan, Kristen O'Dwyer, Jozal Moore, Omer Jamy, Razan Mohty, Muthu Kumaran, Rasmus Hoeg, Wendy Stock, Caspian Oliai, Georgia Lill, Marc Schwartz, Divya Koura, Kaitlyn Dykes, Aaron Logan, Michael Daunov, Ken Byrd, Fevzi Yalniz, Noelle Frey, Matthew Connor, George Yaghmour, Vivian Irizarry Gatell, Clayton Jackson, Olalekan Oluwole, Ali Al-Darobi, Evan Chen, Catherine Lee, Timothy O'Connor, Bhagirathbhai Dholaria, Veronika Bachanova, Sean Tracy, Hrishikesh Srinagesh, Katharine Miller, Katherine Sutherland, Navneet Majhail, Luke Mountjoy, Shahbaz Malik, Aravind Ramakrishnan, Paul Shaughnessy, John Mathews, Eunice Wang, Minoo Battiwalla, Gregory Roloff, Lori Muffly
Abstract Number: abs25-13552
https://meetings-api.hematology.org/api/abstract/vmpreview/302197
Integrative single-cell multi-omic and functional profiling of human bone marrow regulatory T cells to enhance GVHD-preventive cell therapies
Jessica Diarra, Cameron Bader, Daniel Ho, Trevor Bruce , Kent Jensen, Everett Meyer, Sean Bendall
Abstract Number: abs25-13575
https://meetings-api.hematology.org/api/abstract/vmpreview/302220
Observational comparison of orca-T to registry-based post-transplant cyclophosphamide patients using matched unrelated donors
Roni Tamari, Caspian Oliai, Rasmus Hoeg, Arpita Gandhi, Edmund Waller, Sagar Patel, Bhagirathbhai Dholaria, Jeremy Pantin, Amandeep Salhotra, Steven Devine, Alexandra Gomez-Arteaga, Rawan Faramand, Jennifer Holter-Chakrabarty, Betty K. Hamilton, Antonio Jimenez Jimenez, Satyajit Kosuri, Yi-Bin Chen, John Magenau, Alireza Eghtedar, Anna Pavlova, Nate Fernhoff, J. Scott McClellan, Scott Killian, Robert Negrin, Everett Meyer
Abstract Number: abs25-13998
https://meetings-api.hematology.org/api/abstract/vmpreview/302643
Safety and efficacy of BCMA directed CAR-T therapy in older patients (Aged ≥ 75) with relapsed or refractory multiple myeloma (RRMM)
Arash Velayati, Alexandria Jensen, Danai Dima, Masooma Rana, Lauren Peres, Leyla Shune, Brett Reid, Oren Pasvolsky, Andrew Portuguese, Nadine Abdallah, Hitomi Hosoya, Lekha Mikkilineni, Rahul Banerjee, Raffaella Cassano Cassano, Jack Khouri, Christopher Ferreri, Aimaz Afrough, Noa Biran, Sneha Purvey, Gliceida Fortuna, Vanna Hovanky, Douglas Sborov, Kelley Julian, Kimberly Green, Ciara Louise Freeman, Joseph McGuirk, Eli Zolotov, Cindy Varga, Marcus Geer, Omar Puglianini, Utkarsh Goel, Mahmoud Gaballa, Faiz Anwer, Shahzad Raza, Christen Dillard, Saurabh Zanwar, Saurabh Dahiya, David Miklos, James Davis, Megan Herr, Melissa Alsina, Yi Lin, Peter Voorhees, Ran Reshef, Larry Anderson, Krina Patel, Doris Hansen, Surbhi Sidana
Abstract Number: abs25-14100
https://meetings-api.hematology.org/api/abstract/vmpreview/302745
Adult BMT/Cellular Therapy
Lori Muffly
Career Development Lunch at Hyatt - Windermere Ballroom on Saturday, December 6, 11:16 AM - 11:17 AM EST
Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3
María-Victoria Mateos, Nizar Bahlis, Aurore Perrot, Ajay Nooka, Jin Lu, Charlotte Pawlyn, Roberto Mina, Gaston Caeiro, Alain Kentos, Vania Hungria, Donna Reece, Ting Niu, Anne Mylin, Charlotte Hansen, Raphael Teipel, Britta Besemer, Meletios Dimopoulos, Elena Zamagni, Satoshi Yoshihara, Kihyun Kim, Chang-Ki Min, Paulus Geerts, Elena Van Leeuwen-Segarceanu, Agata Tyczynska, Juan Luis Reguera, Magnus Johansson, Markus Hansson, Mehmet Turgut, Mark Grey, Surbhi Sidana, Paula Rodriguez-Otero, Joaquin Martinez-Lopez, Hamza Hashmi, Robin Carson, Rachel Kobos, Weili Sun, Kristen Lantz, Anne Seifert, Debbie Briseno-Toomey, Lisa O'Rourke, Maria Rubin, Diego Vieyra, Lijuan Kang, Luciano Costa
Abstract Number: LBA-6
Prsentation ID LBA-6 - Tuesday, December 9, 08:45 AM - 09:00 AM EST at OCCC - West Hall D2
https://meetings-api.hematology.org/api/abstract/vmpreview/304640